David Fellows

Currently, David A. Fellows is Chairman at Oxular Ltd. since 2017, Director at Glaucoma Foundation since 2006, Director at Gyroscope Therapeutics Ltd. since 2020, Director at Jaguar Therapeutics, Director at Arctos Medical, and Director at Jaguar Gene Therapy LLC since 2020.
Formerly, Mr. Fellows was President, Chief Executive Officer & Director at Beacon Therapeutics (USA), Inc., Chief Executive Officer & Director at Nightstar Therapeutics Ltd. from 2017 to 2019, Chairman at Terns Pharmaceuticals, Inc. from 2021 to 2026, Managing Director at Allergan Ltd., Director at NightstaRx Ltd., Director at Axovia Therapeutics, Inc., Non-Executive Director at Gyroscope Therapeutics Holdings Plc from 2020 to 2022, Vice President at Allergan, Inc., and Vice President at Johnson & Johnson Vision Care, Inc. from 2005 to 2014.
Education includes undergraduate studies at Butler University.